U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07738601) titled 'Patient Reported Outcome Measurement Within the Secured Access to Innovative Medicines for Children With cAncer (SACHA) Study' on July 22.
Brief Summary: Patient-Reported Outcomes (PROs) are patient-centered measures used to assess health status, track changes over time, and evaluate the impact of treatment on the patient's perceived health.
The SACHA study is a French prospective observational study developed by the Societe Francaise de lutte contre les Cancers de l'Enfant et de l'adolescent (SFCE). It prospectively collects real-world safety and activity data on novel therapies given to patients aged 25 or younger with pediatric m...